Author： Poon Ronnie TP Borys Nicholas
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.2, 2009-02, pp. : 333-343
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Doxorubicin liposomal + docetaxel: efficacy in metastatic breast cancer?
Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. :
Access to resources
Recommend
Liposomal doxorubicin effective for advanced breast cancer
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :
Liposomal doxorubicin vs epirubicin in breast cancer
Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. :
By Laginha Kimberley Moase Elaine Yu Ning Huang Anthony Allen T. M.
Journal of Drug Targeting, Vol. 16, Iss. 7-8, 2008-08 ,pp. :
Doxorubicin liposomal in ovarian cancer guidance issued by UK NICE
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. :